OR WAIT 15 SECS
© 2021 MJH Life Sciences™ , Dermatology Times and Multimedia Medical, LLC. All rights reserved.
In patients with chronic plaque psoriasis treatedwith the human LFA-3/IgG1 fusion protein alefacept (Amevive), early reductionin circulating memory-effector CD45RO+ T-cells may be used to predict ultimateclinical improvement,